Literature DB >> 10136366

Development of clinical methods for utilization review in psychiatric day treatment.

K G Terkelsen1, R H McCarthy, R L Munich, B E Hurley.   

Abstract

When a time-limited day treatment program was reconfigured to serve individuals with long-standing psychotic disorders, the number of treatment episodes exceeding six months rose to 70%. To justify this concentration of resources, the program needed methods to identify individuals for whom sustained treatment was appropriate. This report describes development of utilization review methods adapted to publicly funded day treatment of individuals with serious mental illness and training of clinicians in new documentation skills. Data from three years of operation suggest that symptom severity is not a reliable indicator of medical necessity in day treatment. As expected with a clinically based system, a composite measure of benefit and medical necessity indicators weighted toward functioning in living, learning, working, and socializing environments predicted physician reviewer denial of continued day treatment, but length of stay did not.

Entities:  

Mesh:

Year:  1994        PMID: 10136366     DOI: 10.1007/BF02521336

Source DB:  PubMed          Journal:  J Ment Health Adm        ISSN: 0092-8623


  52 in total

1.  The cost of schizophrenia.

Authors:  J G Gunderson; L R Mosher
Journal:  Am J Psychiatry       Date:  1975-09       Impact factor: 18.112

2.  The effect of enrollment in a prepaid health plan on utilization of a community crisis intervention center by chronically mentally ill individuals.

Authors:  T W Dobmeyer; P A McKee; R D Miller; J S Westcott
Journal:  Community Ment Health J       Date:  1990-04

3.  Treatment and the course of schizophrenia.

Authors:  G E Hogarty
Journal:  Schizophr Bull       Date:  1977       Impact factor: 9.306

4.  New directions in research on assertive community treatment.

Authors:  C A Taube; L Morlock; B J Burns; A B Santos
Journal:  Hosp Community Psychiatry       Date:  1990-06

5.  Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates.

Authors:  G E Hogarty; S C Goldberg; N R Schooler; R F Ulrich
Journal:  Arch Gen Psychiatry       Date:  1974-11

6.  Rochester: a comprehensive capitation experiment.

Authors:  H M Babigian; P E Marshall
Journal:  New Dir Ment Health Serv       Date:  1989

7.  Formats for peer review of dynamic psychotherapy.

Authors:  G L Shepherd
Journal:  Hosp Community Psychiatry       Date:  1985-05

8.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

9.  Technique for training schizophrenic patients in illness self-management: a controlled trial.

Authors:  T A Eckman; W C Wirshing; S R Marder; R P Liberman; K Johnston-Cronk; K Zimmermann; J Mintz
Journal:  Am J Psychiatry       Date:  1992-11       Impact factor: 18.112

Review 10.  Chronicity in schizophrenia: fact, partial fact, or artifact?

Authors:  C M Harding; J Zubin; J S Strauss
Journal:  Hosp Community Psychiatry       Date:  1987-05
View more
  1 in total

Review 1.  Measuring the costs of schizophrenia. Implications for the post-institutional era in the US.

Authors:  K G Terkelsen; A Menikoff
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.